1. Boolell M et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47–52.
2. Goldstein I et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397–1404.
3. Sadovsky R, Miller T, Moskowitz M, Hackett G . Three-year update of sildenafil citrate (Viagra®) efficacy and safety. Int J Clin Pract 2001; 55: 115–128.
4. Krane RJ . Changes in ED therapy in the Viagra era. World J Urol 2001; 19: 23–24.
5. Barada J . Successful salvage of sildenafil (Viagra) failures: benefits of patient education and rechallenge with sildenafil. Int J Impot Res 2001; 13(Suppl 4): S49.